216 related articles for article (PubMed ID: 8105213)
1. Randomized double-blind trial of prednisone versus radiotherapy in Graves' ophthalmopathy.
Prummel MF; Mourits MP; Blank L; Berghout A; Koornneef L; Wiersinga WM
Lancet; 1993 Oct; 342(8877):949-54. PubMed ID: 8105213
[TBL] [Abstract][Full Text] [Related]
2. Clinical activity score as a guide in the management of patients with Graves' ophthalmopathy.
Mourits MP; Prummel MF; Wiersinga WM; Koornneef L
Clin Endocrinol (Oxf); 1997 Jul; 47(1):9-14. PubMed ID: 9302365
[TBL] [Abstract][Full Text] [Related]
3. A randomized controlled trial of orbital radiotherapy versus sham irradiation in patients with mild Graves' ophthalmopathy.
Prummel MF; Terwee CB; Gerding MN; Baldeschi L; Mourits MP; Blank L; Dekker FW; Wiersinga WM
J Clin Endocrinol Metab; 2004 Jan; 89(1):15-20. PubMed ID: 14715820
[TBL] [Abstract][Full Text] [Related]
4. Comparison of the effectiveness and tolerability of intravenous or oral glucocorticoids associated with orbital radiotherapy in the management of severe Graves' ophthalmopathy: results of a prospective, single-blind, randomized study.
Marcocci C; Bartalena L; Tanda ML; Manetti L; Dell'Unto E; Rocchi R; Barbesino G; Mazzi B; Bartolomei MP; Lepri P; Cartei F; Nardi M; Pinchera A
J Clin Endocrinol Metab; 2001 Aug; 86(8):3562-7. PubMed ID: 11502779
[TBL] [Abstract][Full Text] [Related]
5. Therapeutic outcome of prednisone medication and of orbital irradiation in patients with Graves' ophthalmopathy.
Wiersinga WM; Smit T; Schuster-Uittenhoeve AL; van der Gaag R; Koornneef L
Ophthalmologica; 1988; 197(2):75-84. PubMed ID: 3186212
[TBL] [Abstract][Full Text] [Related]
6. Orbital radiotherapy combined with high dose systemic glucocorticoids for Graves' ophthalmopathy is more effective than radiotherapy alone: results of a prospective randomized study.
Marcocci C; Bartalena L; Bogazzi F; Bruno-Bossio G; Lepri A; Pinchera A
J Endocrinol Invest; 1991 Nov; 14(10):853-60. PubMed ID: 1802923
[TBL] [Abstract][Full Text] [Related]
7. Prednisone and cyclosporine in the treatment of severe Graves' ophthalmopathy.
Prummel MF; Mourits MP; Berghout A; Krenning EP; van der Gaag R; Koornneef L; Wiersinga WM
N Engl J Med; 1989 Nov; 321(20):1353-9. PubMed ID: 2519530
[TBL] [Abstract][Full Text] [Related]
8. Radiotherapy in the management of Graves' ophthalmopathy.
Sakata K; Hareyama M; Oouchi A; Shidou M; Nagakura H; Morita K; Osanai H; Ohtsuka K; Hinoda Y
Jpn J Clin Oncol; 1998 Jun; 28(6):364-7. PubMed ID: 9730150
[TBL] [Abstract][Full Text] [Related]
9. [Immunosuppressive therapies in patients with Graves' ophthalmopathy].
Wang J; Wang YT; Shao JQ; Wang X; Du H
Zhonghua Nei Ke Za Zhi; 2004 Feb; 43(2):125-7. PubMed ID: 15059413
[TBL] [Abstract][Full Text] [Related]
10. Radiotherapy for Graves' orbitopathy: randomised placebo-controlled study.
Mourits MP; van Kempen-Harteveld ML; García MB; Koppeschaar HP; Tick L; Terwee CB
Lancet; 2000 Apr; 355(9214):1505-9. PubMed ID: 10801172
[TBL] [Abstract][Full Text] [Related]
11. Corticosteroids in Moderate-To-Severe Graves' Ophthalmopathy: Oral or Intravenous Therapy?
Penta L; Muzi G; Cofini M; Leonardi A; Lanciotti L; Esposito S
Int J Environ Res Public Health; 2019 Jan; 16(1):. PubMed ID: 30626069
[TBL] [Abstract][Full Text] [Related]
12. [Treatment of Grave's ophthalmopathy with high doses of corticosteroids].
Cirić J; Zarković M; Stojanović M; Pepenezić Z; Randjelović G; Gligorović M; Trbojević B; Drezgić M; Nesović M
Srp Arh Celok Lek; 2000; 128(5-6):179-83. PubMed ID: 11089418
[TBL] [Abstract][Full Text] [Related]
13. [Soluble IL-2 receptor levels in patients with Graves' ophthalmopathy].
Yang H; Wu Z; Huang X; Xie C; Yang P
Yan Ke Xue Bao; 1999 Jun; 15(2):78-80. PubMed ID: 12579704
[TBL] [Abstract][Full Text] [Related]
14. Combined orbital irradiation and systemic steroids compared with systemic steroids alone in the management of moderate-to-severe Graves' ophthalmopathy: a preliminary study.
Ng CM; Yuen HK; Choi KL; Chan MK; Yuen KT; Ng YW; Tiu SC
Hong Kong Med J; 2005 Oct; 11(5):322-30. PubMed ID: 16219950
[TBL] [Abstract][Full Text] [Related]
15. Relation between therapy for hyperthyroidism and the course of Graves' ophthalmopathy.
Bartalena L; Marcocci C; Bogazzi F; Manetti L; Tanda ML; Dell'Unto E; Bruno-Bossio G; Nardi M; Bartolomei MP; Lepri A; Rossi G; Martino E; Pinchera A
N Engl J Med; 1998 Jan; 338(2):73-8. PubMed ID: 9420337
[TBL] [Abstract][Full Text] [Related]
16. Use of corticosteroids to prevent progression of Graves' ophthalmopathy after radioiodine therapy for hyperthyroidism.
Bartalena L; Marcocci C; Bogazzi F; Panicucci M; Lepri A; Pinchera A
N Engl J Med; 1989 Nov; 321(20):1349-52. PubMed ID: 2811943
[TBL] [Abstract][Full Text] [Related]
17. Orbital cobalt irradiation combined with retrobulbar or systemic corticosteroids for Graves' ophthalmopathy: a comparative study.
Marcocci C; Bartalena L; Panicucci M; Marconcini C; Cartei F; Cavallacci G; Laddaga M; Campobasso G; Baschieri L; Pinchera A
Clin Endocrinol (Oxf); 1987 Jul; 27(1):33-42. PubMed ID: 3308192
[TBL] [Abstract][Full Text] [Related]
18. Orbital cobalt radiotherapy and systemic or retrobulbar corticosteroids for Graves' ophthalmopathy.
Pinchera A; Marcocci C; Bartalena L; Panicucci M; Marconcini C; Lepri A; Cavallacci G; Cartei F; Laddaga M
Horm Res; 1987; 26(1-4):177-83. PubMed ID: 3596466
[TBL] [Abstract][Full Text] [Related]
19. Ciclosporin and prednisone v. prednisone in treatment of Graves' ophthalmopathy: a controlled, randomized and prospective study.
Kahaly G; Schrezenmeir J; Krause U; Schweikert B; Meuer S; Muller W; Dennebaum R; Beyer J
Eur J Clin Invest; 1986 Oct; 16(5):415-22. PubMed ID: 3100309
[TBL] [Abstract][Full Text] [Related]
20. [Treatment of Graves' ophthalmopathy with oral or intravenous corticosteroids].
Brauer VF; Scholz GH
Med Klin (Munich); 2004 Feb; 99(2):71-6. PubMed ID: 14963657
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
